Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kaser, Muzaffer ^a,b,c   Soltesz, Fruzsina ^d   Lawrence, Phil ^d   Miller, Sam ^d   Dodds, Chris ^d   Croft, Rodney ^e   Dudas, Robert B ^a,f   Zaman, Rashid ^a,g   Fernandez Egea, Emilio ^a,c,f   Müller, Ulrich ^a,f   Dean, Anna ^a   Bullmore, Edward T ^a,c,d,f   Nathan, Pradeep J ^a,h,i  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BAHCESEHIR UNIVERSITY   (Turkey)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY OF WOLLONGONG   (Australia)

^f CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^g Monash University ^*  (United Kingdom)

^h MONASH UNIVERSITY   (Australia)

ⁱ UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; LONG ACTING DRUG; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MENTAL PERFORMANCE; MIDDLE AGED; MISMATCH NEGATIVITY; MISMATCH NEGATIVITY IMPAIRMENT; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; SCHIZOPHRENIA; SOCIAL INTERACTION; THETA RHYTHM; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; COGNITION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEGATIVISM; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84892904031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083255     Document Type: Article

References (68)

1. Kurtz MM (2005) Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr Res 74(1): 15-26. doi:10.1016/j.schres.2004. 07.005. PubMed: 15694750.
2. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L (2005) A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev 15(2): 73-95. doi:10.1007/s11065-005-6254-9. PubMed: 16211467.
3. Kurtz MM, Tolman A (2011) Neurocognition, Insight into Illness and Subjective Quality-of-Life in Schizophrenia: What is Their Relationship? Schizophr Res 127(1-3): 157-162. doi:10.1016/j.schres.2010.12.004. PubMed: 21211943.
4. Butler PD, Chen Y, Ford JM, Geyer MA, Silverstein SM et al. (2012) Perceptual Measurement in Schizophrenia: Promising Electrophysiology and Neuroimaging Paradigms From CNTRICS. Schizophr Bull 38(1): 81-91. doi:10.1093/schbul/sbr106. PubMed: 21890745.
5. Näätänen R, Gaillard AWK, Mäntysalo S (1978) Early selective-attention effect on evoked potential reinterpreted. Acta Psychol (Amst) 42: 313-329. doi:10.1016/0001-6918(78)90006-9. PubMed: 685709.
6. Todd J, Michie PT, Schall U, Ward PB, Catts SV (2012) Mismatch negativity (MMN) reduction in schizophrenia-impaired prediction-error generation, estimation or salience? International Journal of Psychophysiology 83(2): 222-231. doi:10.1016/j.ijpsycho.2011.10.003. PubMed: 22020271.
7. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S et al. (1991) Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 30: 1059-1062. doi: 10.1016/0006-3223(91)90126-7. PubMed: 1756198.
8. Devrim-Uçok M, Keskin-Ergen HY, Uçok A (2008) Mismatch negativity at acute and post-acute phases of first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 258(3): 179-185. doi:10.1007/s00406-007-0772-9. PubMed: 18000635.
9. Umbricht D, Koller R, Schmid L, Skrabo A, Grübel C et al. (2003) How Specific Are Deficits in Mismatch Negativity Generation to Schizophrenia? Biol Psychiatry 53: 1120-1131. doi:10.1016/S0006-3223(02)01642-6. PubMed: 12814863.
10. Umbricht D, Krljes S (2005) Mismatch negativity in schizophrenia: A meta-analysis. Schizophr Res 76: 1-23. doi:10.1016/j.schres.2004.12.002. PubMed: 15927795.
11. Korostenskaja M, Dapsys K, Siurkute A, Maciulis V, Ruksenas O et al. (2005) Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 29(4): 543-548. doi:10.1016/j.pnpbp.2005.01.019. PubMed: 15866356.
12. Schall U, Catts SV, Chaturvedi S, Liebert B, Redenbach J et al. (1998) The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. Int J Neuropsychopharmacol 1(1): 19-29. doi:10.1017/S146114579800100X. PubMed: 11281941.
13. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R et al. (1994) Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses. Arch Gen Psychiatry 51(3): 199-214. doi: 10.1001/archpsyc.1994.03950030035004. PubMed: 8122957.
14. Tikhonravov D, Neuvonen T, Pertovaara A, Savioja K, Ruusuvirta T et al. (2008) Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats. Brain Res 1203(8):97-102. PubMed: 18325485.
15. Cooper RJ, Atkinson RJ, Clark RA, Michie PT (2013) Event-related potentials reveal modelling of auditory repetition in the brain. Int J Psychophysiol 88: 74-81. doi:10.1016/j.ijpsycho.2013.02.003. PubMed: 23454030.
16. Baldeweg T, Klugman A, Gruzelier J, Hirsch SR (2004) Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophr Res 69: 203-217. doi:10.1016/j.schres.2003.09.009. PubMed: 15469194.
17. Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL et al. (2012) Automatic Sensory Information Processing Abnormalities across the Illness Course of Schizophrenia. Psychol Med 42(1): 85-97. doi: 10.1017/S0033291711001061. PubMed: 21740622.
18. Light GA, Braff DL (2005) Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am J Psychiatry 162: 1741-1743. doi:10.1176/appi.ajp.162.9.1741. PubMed: 16135637.
19. Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA et al. (2012) Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLOS ONE 7(7): e39434. doi:10.1371/journal.pone.0039434. PubMed: 22802938.
20. Tervaniemi M, Lehtokoski A, Sinkkonen J, Virtanen J, Ilmoniemi RJ et al. (1999) Test-retest reliability of mismatch negativity for duration, frequency and intensity changes. Clin Neurophysiol 110: 1388-1393. doi:10.1016/S1388- 2457(99)00108-X. PubMed: 10454274.
21. Michie PT, Innes-Brown H, Todd J (2002) Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biol Psychiatry 52(7): 749-758. doi:10.1016/S0006-3223(02)01379-3. PubMed: 12372666.
22. Şevik AE, Anil Yaǧcioǧlu E, Yaǧcioǧlu S, Karahan S, Gürses N et al. (2011) Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study. Schizophr Res 130(1-3): 195-202. doi:10.1016/j.schres.2011.04. 018. PubMed: 21592733.
23. Bramon E, Croft RJ, McDonald C, Virdi GK, Gruzelier JG et al. (2004) Mismatch negativity in schizophrenia: a family study. Schizophr Res 67(1): 1-10. doi:10.1016/S0920-9964(03)00132-4. PubMed: 14741319.
24. Toyomaki A, Kusumi I, Matsuyama T, Kako Y, Ito K et al. (2008) Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia. Progress in Neuropsychopharmacol and Biological Psychiatry 32(1): 95-99.
25. Brockhaus-Dumke A, Tendolkar I, Pukrop R, Schultze-Lutter F, Klosterkötter J et al. (2005) Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr Res 73: 297-310. doi:10.1016/j.schres.2004.05.016. PubMed: 15653275.
26. Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A et al. (2007) Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB. Eur Psychiatry 22: 104-115. doi:10.1016/j.eurpsy.2007.01.330. PubMed: 17227707.
27. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM et al. (2010) Assessing cognitive functions in clinical trials of schizophrenia. Neuroscience and Biobehav Reviews 34: 1161-1177.
28. Robbins TW (2005) Synthesizing schizophrenia: a bottom-up, symptomatic approach. Schizophr Bull 31: 854-864. doi:10.1093/schbul/sbi044. PubMed: 16107585.
29. Buzsáki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304(5679): 1926-1929. doi:10.1126/science.1099745. PubMed: 15218136.
30. Başar E, Başar-Eroglu C, Karakaş S, Schürmann M (2001) Gamma, alpha, delta, and theta oscillations govern cognitive processes. International Journal of Psychophysiology 39(2): 241-248.
31. Kirino E (2007) Mismatch negativity correlates with delta and theta EEG power in schizophrenia. Int J Neurosci 17(9): 1257-1279. PubMed: 17654091.
32. Rodionov V, Durst R, Mager M, Teitelbaum A, Raskin S et al. (2009) Wavelet Analysis of the Frontal Auditory Evoked Potentials Obtained in the Passive Oddball Paradigm in Healthy Subjects and Schizophrenics. J Basic Clin Physiol Pharmacol 20(3): 233-264. PubMed: 19852310.
33. Fuentemilla L, Marco-Pallarés J, Münte TF, Grau C (2008) Theta EEG oscillatory activity and auditory change detection. Brain Res 1220: 93-101. doi:10.1016/j.brainres.2007.07.079. PubMed: 18076870.
34. Ko D, Kwon S, Lee GT, Im CH, Kim KH et al. (2012) Theta Oscillation Related to the Auditory Discrimination Process in Mismatch Negativity: Oddball versus Control Paradigm. J Clin Neurol 8(1): 35-42. doi: 10.3988/jcn.2012.8.1. 35. PubMed: 22523511.
35. Makeig S (1993) Auditory event-related dynamics of the EEG spectrum and effects of exposure to tones. Electroencephalogr Clin Neurophysiol 86(4): 283-293. doi:10.1016/0013-4694(93)90110-H. PubMed: 7682932.
36. Bishop DVM, Hardiman MJ (2010) Measurement of mismatch negativity in individuals: A study using single trial analysis. Psychophysiology 47(4): 697-705. PubMed: 20210877.
37. Delorme A, Makeig S (2004) EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 134(1): 9-21. doi:10.1016/j.jneumeth.2003.10.009. PubMed: 15102499.
38. Tallon-Baudry C, Bertrand O, Delpuech C, Pernier J (2004) Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual responses in human. Journal of Neuroscience 16(13): 4240-4249. PubMed: 8753885.
39. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E et al. (1997) Reliability and Validity of the MINI International Neuropsychiatric Interview (M.I.N.I.) according to the SCID-P. European Psychiatry 12: 232-241. doi:10.1016/S0924-9338(97)80737-7.
40. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13: 261-276. doi: 10.1093/schbul/13.2. 261. PubMed: 3616518.
41. Flemenbaum A, Zimmermann RL (1973) Inter and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 32(3): 783-792. PubMed: 4704758.
42. Beck AT, Steer RA, Brown GK (1996) BDI-II: Beck Depression Inventory-II. Psychological Corp, San Antonio, TX.
43. Steer RA, Rissmiller DJ, Ranieri WF, Beck AT (1993) Structure of the computer-assisted Beck Anxiety Inventory with psychiatric inpatients. J Pers Assess 60(3): 532-542. doi:10.1207/s15327752jpa6003-10. PubMed: 8336268.
44. Axelrod BN (2002) Validity of the Wechsler abbreviated scale of intelligence and other very short forms of estimating intellectual functioning. Assessment 9: 17-23. doi: 10.1177/1073191102009001003. PubMed: 11911230.
45. Bright P, Jaldow E, Kopelman MD (2002) The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc 8(6): 847-854. doi:10.1017/S1355617702860131. PubMed: 12240749.
46. Mundt JC, Marks IM, Shear KM, Greist JH (2002) The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 180(5): 461-464. doi:10.1192/bjp.180.5.461. PubMed: 11983645.
47. CANTABeclipse, 2011. Test Administration Guide. Cambridge Cognition Limited.Manual Version 4.0.0
48. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Annals of Statistics: 1165-1188.
49. Friston K (2005) A theory of cortical responses. Philosophical transactions of the Royal Society B: Biological sciences 360(1456):815-36
50. Hsiao FJ, Wu ZA, Ho LT, Lin YY (2009) Theta oscillation during auditory change detection: an MEG study. Biol Psychol 81(1): 58-66. doi:10.1016/j. biopsycho.2009.01.007. PubMed: 19428969.
51. Başar-Eroglu C, Başar E, Demiralp T, Schürmann M (1992) P300-response: possible psychophysiological correlates in delta and theta frequency channels. A review. Int J Psychophysiol 13(2): 161-179. doi: 10.1016/0167-8760(92)90055-G. PubMed: 1399755.
52. Yordanova J, Falkenstein M, Hohnsbein J, Kolev V (2004) Parallel systems of error processing in the brain. NeuroImage 22(2): 590-602. doi:10.1016/j.neuroimage.2004.01.040. PubMed: 15193587.
53. Demiralp T, Ademoglu A, Comerchero M, Polich J (2001) Wavelet analysis of P3a and P3b. Brain Topogr 13(4): 251-267. doi:10.1023/A:1011102628306. PubMed: 11545154.
54. Bates AT, Kiehl KA, Laurens KR, Liddle PF (2009) Low-frequency EEG oscillations associated with information processing in schizophrenia. Schizophr Res 115(2): 222-230. PubMed: 19850450.
55. Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y et al. (2012) Disentangling early sensory information processing deficits in schizophrenia. Clin Neurophysiol 123: 1942-1949. doi:10.1016/j.clinph.2012.02. 079. PubMed: 22608970.
56. Zhou Z, Zhu H, Chen L (2013) Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia. PLOS ONE 8(1): e52186. doi: 10.1371/journal.pone.0052186. PubMed: 23308105.
57. Keefe RE, Bilder RM, Davis SM, Harvey PD, Palmer BW et al. (2007) Neurocognitive Effects of Antipsychotic Medications in Patients with Chronic Schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64(6):633-647. doi:10.1001/archpsyc.64.6.633. PubMed: 17548746.
58. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26: 365-384. PubMed: 16773445.
59. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996) Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A 93(21): 11962-11967. doi:10.1073/pnas.93.21.11962. PubMed: 8876245.
60. Leung S, Croft RJ, Guille V, Scholes K, O'Neill BV et al. (2010) Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology (Berl) 208(2): 233-244. doi:10.1007/s00213-009-1723-0. PubMed: 20012022.
61. Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal MJ, Finkel LH et al. (2010) Ketamine modulates theta and gamma oscillations. J Cogn Neurosci 22(7): 1452-1464. doi:10.1162/jocn.2009.21305. PubMed: 19583475.
62. van Wingerden M, Vinck M, Tijms V, Ferreira IRS, Jonker AJ et al. (2012) NMDA Receptors Control Cue-Outcome Selectivity and Plasticity of Orbitofrontal Firing Patterns during Associative Stimulus-Reward Learning. Neuron 76(4): 813-825. doi:10.1016/j.neuron.2012.09.039. PubMed: 23177965.
63. Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA (2007) Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 33(5): 1120-1130. doi:10.1093/schbul/sbm083. PubMed: 17641146.
64. Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE et al. (2012) Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Neuropsychopharmacology 37(4): 865-875. doi:10.1038/npp.2011.261. PubMed: 22030715.
65. Astikainen P, Stefanics G, Nokia M, Lipponen A, Cong F et al. (2011) Memory-based mismatch response to frequency changes in rats. PLOS ONE 6(9): e24208. doi:10.1371/journal.pone.0024208. PubMed: 21915297.
66. Kawakubo Y, Kasai K (2006) Support for an association between mismatch negativity and social functioning in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 30(7): 1367-1368. doi:10.1016/j.pnpbp.2006.03.003. PubMed: 16603302.
67. Rasser PE, Schall U, Todd J, Michie PT, Ward PB et al. (2011) Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull 37(1): 131-140. doi:10.1093/schbul/sbp060. PubMed: 19561058.
68. Wynn JK, Sugar C, Horan WP, Kern R, Green MF (2010) Mismatch Negativity, Social Cognition, and Functioning in Schizophrenia Patients. Biol Psychiatry 67(10): 940-947. doi:10.1016/j.biopsych.2009.11.024. PubMed: 20074704.